Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DCL000210

Drug Information
CompanyMerck-Serono Lab
IndicationHaematological Malignancies
[ICD9: 200-209   ICD10: C81-C96]
Phase I    
Therapeutic ClassAntineoplastic Agents
Ref 1J Cancer Res Clin Oncol. 2010 Jan;136(1):99-113.Preclinical characterization of Aurora kinase inhibitor R763/AS703569 identified through an image-based phenotypic screen. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543